Coronary Artery Disease (CAD) is the most common heart disease and relates to the build-up of plaque in the arteries that supply blood to the heart and can lead to heart attacks.
Currently available tests require years of disease progression and plaque development before they are able to detect CAD. This results in delayed diagnosis and missed opportunities to intervene and reduce the risk of heart attack.
Inflammation in the coronary arteries causes plaque development (fatty deposits inside the arteries) and makes them more prone to rupture or erode, which can result in a heart attack. Knowing whether we have high or low coronary inflammation can help clinicians prescribe treatments to prevent the development of CAD and stabilise dangerous plaques.
You can do something about it! Making lifestyle changes, along with prescribed medications, to reduce inflammation can help treat the disease and lower the overall risk of having a heart attack.
It is the only commercially available solution to detect coronary inflammation and has been validated across tens of thousands of cardiac CT scans in one of the largest clinical studies at the University of Oxford.
This study has revealed that even among patients with no or minimal plaque, those with high inflammation on their CaRi-Heart scan experienced an 11x increased risk of a fatal cardiac event.
CaRi-Heart analysis can be performed on a patient’s routine coronary CT angiography (CCTA) scan. The analysis report provides a personalised assessment of coronary inflammation and cardiac risk.
(Lancet 2024, https://doi.org/10.1016/S0140-6736(24)00596-8)
Speak to your clinician to learn more about CaRi-Heart technology.
